Quotient Sciences Header

Quotient Sciences Header

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Filters

Reset Filter

All Developments

Product Type

Companies

Enthera Pharmaceuticals

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Enthera Pharmaceuticals Extends Series A Financing, Raising a Total Of €35m

Details:

The proceeds from the Series A financing will be used to obtain clinical proof-of-concept through a first-in-human study of Ent001, Enthera’s lead candidate.

Lead Product(s): Ent001

Therapeutic Area: Endocrinology Product Name: Ent001

Highest Development Status: Preclinical Product Type: Large molecule

Partner/Sponsor/Collaborator: Roche Venture Fund

Deal Size: $42.3 million Upfront Cash: Undisclosed

Deal Type: Series A Financing January 28, 2021

ASK
US

Upload
your Pipeline Activity

Enthera Pharmaceuticals

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Enthera Pharmaceuticals Raises €28 Million in Series A Financing to Advance Restorative Therapy for Type 1 Diabetes and IBD

Details:

Proceeds to be used for clinical proof-of-concept for lead product Ent001 (IGFBP3/TMEM219 inhibitor) for type 1 diabetes, gastrointestinal diseases and progress pipeline assets.

Lead Product(s): Ent001

Therapeutic Area: Endocrinology Product Name: Ent001

Highest Development Status: Preclinical Product Type: Large molecule

Partner/Sponsor/Collaborator: Sofinnova Partners

Deal Size: $33.1 million Upfront Cash: Undisclosed

Deal Type: Series A Financing July 28, 2020

ASK
US

Upload
your Pipeline Activity

POST ENQUIRY